TheCable·3 min read·medium
ALERT: NAFDAC warns against fake diabetes drugs in circulation
T
Theophilus Adedokun
✦AI Summary
Nigeria's NAFDAC has issued a warning regarding counterfeit versions of the diabetes medication Forxiga circulating in the country. The agency identified fake products mimicking the brand identity of AstraZeneca and warned of serious health risks.
The National Agency for Food and Drug Administration and Control (NAFDAC) has warned against the use of suspected counterfeit medicinal products mimicking Forxiga (dapagliflozin) that are in circulation.
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in